Faculty Opinions recommendation of Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators: The RAID Trial.

Author(s):  
Juan-Carlos Kaski ◽  
Amelia Carro
2016 ◽  
Vol 23 (1) ◽  
pp. 12
Author(s):  
Shervin Eshaghian

Implantable Cardioverter Defibrillators (ICDs) have evolved from a treatment of last resort to the current and rapidly growing use as a first line therapeutic option. Early clinical trials captured what had only been apparent in observational studies that subsequently paved the way for the utilization of ICDs as secondary prevention in patients who had survived life-threatening arrhythmias. As a result, these randomized clinical trials exhibited a benefit with ICD only in high-risk patients with ischemic cardiomyopathy. However, recent studies have been able to demonstrate a significant role for primary prevention in selected high-risk patients with non-ischemic cardiomyopathy.


2018 ◽  
Vol 72 (6) ◽  
pp. 636-645 ◽  
Author(s):  
Wojciech Zareba ◽  
James P. Daubert ◽  
Christopher A. Beck ◽  
David T. Huang ◽  
Jeffrey D. Alexis ◽  
...  

2001 ◽  
Vol 120 (5) ◽  
pp. A376-A376
Author(s):  
B JEETSANDHU ◽  
R JAIN ◽  
J SINGH ◽  
M JAIN ◽  
J SHARMA ◽  
...  

2005 ◽  
Vol 173 (4S) ◽  
pp. 436-436
Author(s):  
Christopher J. Kane ◽  
Martha K. Terris ◽  
William J. Aronson ◽  
Joseph C. Presti ◽  
Christopher L. Amling ◽  
...  

2004 ◽  
Vol 171 (4S) ◽  
pp. 263-263
Author(s):  
Nathalie Rioux-Leclercq ◽  
Florence Jouan ◽  
Pascale Bellaud ◽  
Jacques-Philippe Moulinoux ◽  
Karim Bensalah ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document